Farmacias Benavides S.A.B. de C.V.
Farmacias Benavides, S.A.B. de C.V. engages in the retail of health and wellness products. The company also provides medicamentos, non-perishable food, and hygiene and beauty products, as well as photography. The company was founded in 1917 and is based in Monterrey, Mexico. Farmacias Benavides, S.A.B. de C.V. operates as a subsidiary of Walgreens Boots Alliance, Inc.
Farmacias Benavides S.A.B. de C.V. (BEVIDESB) - Net Assets
Latest net assets as of September 2018: MX$616.48 Million MXN
Based on the latest financial reports, Farmacias Benavides S.A.B. de C.V. (BEVIDESB) has net assets worth MX$616.48 Million MXN as of September 2018.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (MX$6.11 Billion) and total liabilities (MX$5.49 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | MX$616.48 Million |
| % of Total Assets | 10.1% |
| Annual Growth Rate | -3.57% |
| 5-Year Change | 49.49% |
| 10-Year Change | -72.03% |
| Growth Volatility | 41.85 |
Farmacias Benavides S.A.B. de C.V. - Net Assets Trend (2000–2023)
This chart illustrates how Farmacias Benavides S.A.B. de C.V.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Farmacias Benavides S.A.B. de C.V. (2000–2023)
The table below shows the annual net assets of Farmacias Benavides S.A.B. de C.V. from 2000 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | MX$418.05 Million | +130.00% |
| 2022-12-31 | MX$181.76 Million | +545.03% |
| 2021-12-31 | MX$-40.84 Million | -3.58% |
| 2020-12-31 | MX$-39.43 Million | -114.10% |
| 2019-12-31 | MX$279.65 Million | -36.61% |
| 2018-12-31 | MX$441.17 Million | -39.20% |
| 2017-12-31 | MX$725.59 Million | -48.59% |
| 2016-12-31 | MX$1.41 Billion | -6.87% |
| 2015-12-31 | MX$1.52 Billion | +1.40% |
| 2014-12-31 | MX$1.49 Billion | -3.57% |
| 2013-12-31 | MX$1.55 Billion | +0.04% |
| 2012-12-31 | MX$1.55 Billion | +2.75% |
| 2011-12-31 | MX$1.51 Billion | +13.78% |
| 2010-12-31 | MX$1.33 Billion | -6.24% |
| 2009-12-31 | MX$1.41 Billion | +3.22% |
| 2008-12-31 | MX$1.37 Billion | -3.53% |
| 2007-12-31 | MX$1.42 Billion | +9.73% |
| 2006-12-31 | MX$1.29 Billion | +12.84% |
| 2005-12-31 | MX$1.15 Billion | +0.68% |
| 2004-12-31 | MX$1.14 Billion | +13.08% |
| 2003-12-31 | MX$1.01 Billion | +9.13% |
| 2002-12-31 | MX$922.70 Million | +22.28% |
| 2001-12-31 | MX$754.56 Million | -21.71% |
| 2000-12-31 | MX$963.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Farmacias Benavides S.A.B. de C.V.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 142.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | MX$908.01 Million | 217.20% |
| Total Equity | MX$418.05 Million | 100.00% |
Farmacias Benavides S.A.B. de C.V. Competitors by Market Cap
The table below lists competitors of Farmacias Benavides S.A.B. de C.V. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eildon Capital Group
AU:EDC
|
$17.75 Million |
|
SYSTEM1 GROUP LS-01
F:BBA
|
$17.77 Million |
|
Applus Servicios Tecnologicos
MC:APPS
|
$17.77 Million |
|
Thai Rung Union Car Public Company Limited
BK:TRU
|
$17.77 Million |
|
Kwang Myung El
KO:017040
|
$17.74 Million |
|
SAREUM HLDGS LS-0125
F:RYH0
|
$17.74 Million |
|
P5X0
F:P5X0
|
$17.73 Million |
|
Hotel Holiday Garden
TW:2702
|
$17.73 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Farmacias Benavides S.A.B. de C.V.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 181,758,000 to 418,052,000, a change of 236,294,000 (130.0%).
- Net income of 282,332,000 contributed positively to equity growth.
- Other factors decreased equity by 46,038,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | MX$282.33 Million | +67.54% |
| Other Changes | MX$-46.04 Million | -11.01% |
| Total Change | MX$- | 130.00% |
Book Value vs Market Value Analysis
This analysis compares Farmacias Benavides S.A.B. de C.V.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 25.43x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 14.65x to 25.43x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | MX$1.77 | MX$26.00 | x |
| 2018-12-31 | MX$1.08 | MX$26.00 | x |
| 2019-12-31 | MX$0.68 | MX$26.00 | x |
| 2020-12-31 | MX$-0.10 | MX$26.00 | x |
| 2021-12-31 | MX$-0.10 | MX$26.00 | x |
| 2022-12-31 | MX$0.44 | MX$26.00 | x |
| 2023-12-31 | MX$1.02 | MX$26.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Farmacias Benavides S.A.B. de C.V. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 67.54%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.64%
- • Asset Turnover: 1.92x
- • Equity Multiplier: 21.47x
- Recent ROE (67.54%) is above the historical average (2.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 14.42% | 2.40% | 2.08x | 2.89x | MX$40.70 Million |
| 2005 | 12.40% | 2.28% | 2.27x | 2.39x | MX$27.54 Million |
| 2006 | 19.23% | 3.36% | 2.29x | 2.49x | MX$119.34 Million |
| 2007 | 17.39% | 2.69% | 2.34x | 2.76x | MX$104.83 Million |
| 2008 | 6.01% | 0.83% | 2.30x | 3.16x | MX$-54.59 Million |
| 2009 | 7.73% | 1.09% | 2.54x | 2.80x | MX$-32.14 Million |
| 2010 | 6.56% | 0.90% | 2.44x | 2.98x | MX$-45.53 Million |
| 2011 | 13.77% | 2.05% | 2.44x | 2.76x | MX$56.82 Million |
| 2012 | 16.66% | 2.43% | 2.41x | 2.85x | MX$103.24 Million |
| 2013 | 19.27% | 2.70% | 2.19x | 3.27x | MX$143.72 Million |
| 2014 | 6.77% | 0.88% | 2.06x | 3.72x | MX$-48.27 Million |
| 2015 | 0.32% | 0.04% | 2.40x | 3.50x | MX$-146.75 Million |
| 2016 | -7.42% | -0.78% | 2.35x | 4.04x | MX$-245.83 Million |
| 2017 | -94.22% | -5.06% | 2.35x | 7.93x | MX$-756.17 Million |
| 2018 | -69.19% | -2.21% | 2.16x | 14.51x | MX$-349.35 Million |
| 2019 | -48.88% | -0.98% | 1.60x | 31.01x | MX$-164.66 Million |
| 2020 | 0.00% | -2.01% | 1.77x | 0.00x | MX$-274.24 Million |
| 2021 | 0.00% | 0.07% | 2.14x | 0.00x | MX$13.80 Million |
| 2022 | 70.04% | 0.78% | 2.10x | 42.50x | MX$109.13 Million |
| 2023 | 67.54% | 1.64% | 1.92x | 21.47x | MX$240.53 Million |
Industry Comparison
This section compares Farmacias Benavides S.A.B. de C.V.'s net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $6,201,384,000
- Average return on equity (ROE) among peers: 14.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Farmacias Benavides S.A.B. de C.V. (BEVIDESB) | MX$616.48 Million | 14.42% | 8.90x | $17.74 Million |
| Corporativo Fragua S.A.B. de C.V (FRAGUAB) | $6.20 Billion | 14.65% | 0.91x | $246.39K |